In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...

It began in 2020 with a coordinated push to generate public backlash to lockdowns. The ultimate aim was restoring normalcy, ending a politically and economically inconvenient crisis. Over time, ...

The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula for COVID-19 vaccines for 2025-2026.

The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...

The new "regulatory framework for COVID-19 vaccination" laid out by the FDA's new leadership under Health ... ahead of a key meeting of the agency's outside vaccine advisers this Thursday, to ...

Here, we take a look at who’s in at the FDA, who’s out, and what could be next for the agency’s leadership ... navigating the future of the FDA’s vaccine division at a time when HHS ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

Advertisement Advertisement The new FDA leadership still recommends ... since they would be conducted after the vaccine is released in what the agency calls post-marketing studies.

an oncologist who has previously criticized FDA leadership and COVID-19 mandates, as the director of its Center for Biologics Evaluation and Research, the agency said on Tuesday. In that role ...

US FDA Names Agency Critic Vinay Prasad as Top Vaccine Official By Dan Levine ... an oncologist who has previously criticized FDA leadership and COVID-19 mandates, as the director of its Center ...